Association between ALDH1+/CD133+ stem-like cells and tumor angiogenesis in invasive ductal breast carcinoma

Oncology Letters

Volumn 11, Issue 3, 2016, Pages 1750-1756

  Lv, Xinquan ^a   Wang, Yingzi ^a   Song, Yimin ^a   Pang, Xia ^a   Li, Huixiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Aldehyde dehydrogenase 1+ cluster of differentiation 133+ stem like cells; Invasive ductal breast carcinoma; Tumor angiogenesis; Tumor stem cells

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; CD133 ANTIGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STEM CELL; CAPILLARY DENSITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MIDDLE AGED; PAGET NIPPLE DISEASE; PROTEIN EXPRESSION;

EID: 84958042581     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.4145     Document Type: Article

References (34)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
2. Curado MP: Breast cancer in the world: Incidence and mortality. Salud Publica Mex 53: 372-384, 2011.
3. Li CI, Anderson BO, Daling JR and Moe RE: Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289: 1421-1424, 2003.
4. Ernster VL, Barclay J, Kerlikowske K, Grady D and Henderson C: Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275: 913-918, 1996.
5. Lee S, Stewart S, Nagtegaal I, Luo J, Wu Y, Colditz G, Medina D and Allred DC: Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. Cancer Res 72: 4574-4586, 2012.
6. Wojnar A, Pula B, Piotrowska A, Jethon A, Kujawa K, Kobierzycki C, Rys J, Podhorska-Okolow M and Dziegiel P: Correlation of intensity of MT-I/II expression with Ki-67 and MCM-2 proteins in invasive ductal breast carcinoma. Anticancer Res 31: 3027-3033, 2011.
7. Nanashima A, Hatachi G, Tsuchiya T, Matsumoto H, Arai J, Abo T, Murakami G, Tominaga T, Takagi K and Nagayasu T: Clinical significances of cancer stem cells markers in patients with intrahepatic cholangiocarcinoma who underwent hepatectomy. Anticancer Res 33: 2107-2114, 2013.
8. Madjd Z, Ramezani B, Molanae S and Asadi-Lari M: High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas. Asian Pac J Cancer Prev 13: 2973-2978, 2012.
9. Gil J, Stembalska A, Pesz KA and Sasiadek MM: Cancer stem cells: The theory and perspectives in cancer therapy. J Appl Genet 49: 193-199, 2008.
10. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, et al: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567, 2007.
11. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C and Tabar V: Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468: 829-833, 2010.
12. O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110, 2007.
13. Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau CK, Li ML, Tam KH, Lam CT, Poon RT and Fan ST: Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 47: 919-928, 2008.
14. Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV and Varticovski L: Brca1 breast tumors contain distinct CD44+/CD24-and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 10: R10, 2008.
15. Wu Y and Wu PY: CD133 as a marker for cancer stem cells: Progresses and concerns. Stem Cells Dev 18: 1127-1134, 2009.
16. Frierson HF Jr, Wolber RA, Berean KW, Franquemont DW, Gaffey MJ, Boyd JC and Wilbur DC: Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103: 195-198, 1995.
17. Mylona E, Giannopoulou I, Fasomytakis E, Nomikos A, Magkou C, Bakarakos P and Nakopoulou L: The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas. Human Pathol 39: 1096-1102, 2008.
18. Jasani B and Rhodes A: The role and mechanism of high-temperature antigen retrieval in diagnostic pathology. Curr Diag Pathol 7: 153-160, 2001.
19. Currie MJ, Beardsley BE, Harris GC, Gunningham SP, Dachs GU, Dijkstra B, Morrin HR, Wells JE and Robinson BA: Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: Relationships with markers of tumor hypoxia and microvascularity. Human Pathol 44: 402-411, 2013.
20. Shimizu M, Saitoh Y and Itoh H: Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues. Hum Pathol 21: 607-612, 1990.
21. Moeller BJ, Cao Y, Li CY and Dewhirst MW: Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules. Cancer cell 5: 429-441, 2004.
22. Horbinski C, Mojesky C and Kyprianou N: Live free or die: Tales of homeless (cells) in cancer. Am J Pathol 177: 1044-1052, 2010.
23. Duffy JP, Eibl G, Reber HA and Hines OJ: Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer. Mol Cancer 2: 12, 2003.
24. Wei B, Han XY, Qi CL, Zhang S, Zheng ZH, Huang Y, Chen TF and Wei HB: Coaction of spheroid-derived stem-like cells and endothelial progenitor cells promotes development of colon cancer. PloS One 7: e39069, 2012.
25. Martin TA and Jiang WG: Evaluation of the expression of stem cell markers in human breast cancer reveals a correlation with clinical progression and metastatic disease in ductal carcinoma. Oncol Rep 31: 262-272, 2014.
26. Platet N, Liu SY, Atifi ME, Oliver L, Vallette FM, Berger F and Wion D: Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett 258: 286-290, 2007.
27. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD and Rich JN: Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66: 7843-7848, 2006.
28. Panchision DM: The role of oxygen in regulating neural stem cells in development and disease. J Cell Physiol 220: 562-568, 2009.
29. Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T, Kassam AB, et al: Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α. Oncogene 28: 3949-3959, 2009.
30. Ping YF, Yao XH, Jiang JY, Zhao LT, Yu SC, Jiang T, Lin MC, Chen JH, Wang B, Zhang R, et al: The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. J Pathol 224: 344-354, 2011.
31. Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, et al: Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res 71: 3991-4001, 2011.
32. Fanelli M, Locopo N, Gattuso D and Gasparini G: Assessment of tumor vascularization: Immunohistochemical and non-invasive methods. Int J Biol Markers 14: 218-231, 1999.
33. Pufe T, Harde V, Petersen W, Goldring MB, Tillmann B and Mentlein R: Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes. J Pathol 202: 367-374, 2004.
34. Takase Y, Kai K, Masuda M, Akashi M and Tokunaga O: Endoglin (CD105) expression and angiogenesis status in small cell lung cancer. Pathol Res Pract 206: 725-730, 2010.